Fibro Daily

Single Injection Potential Treatment for Chronic Pain

Fibro Daily July 17, 2013

AYX1, an investigational drug designed to treat acute post-surgical pain, has been granted Fast Track Designation by the FDA for the prevention of chronic pain. Adynxx is currently enrolling a study to determine the safety and effectiveness of AYX1 to reduce or prevent post-surgical pain. AYX1  is administered as a single injection after surgery and works by utilizing synthetic pieces of DNA that inhibit the activity of transcription factors, which reduces the number of redundant and pain related-proteins.

Read more: Single Injection Could Potentially Prevent Chronic Pain



Powered by Facebook Comments

Tagged with:

Leave a Comment

Login to your account

Can't remember your Password ?

Register for this site!